CME Group Inc. (NASDAQ:CME) Stock Holdings Increased by Magnolia Capital Advisors LLC

This article was originally published on this site

Magnolia Capital Advisors LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 3.0% during the 4th quarter, Holdings Channel reports. The fund owned 2,264 shares of the financial services provider’s stock after purchasing an additional 65 shares during the period. Magnolia Capital Advisors LLC’s holdings in CME Group were worth $412,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. OLD Dominion Capital Management Inc. raised its stake in CME Group by 2.6% during the 4th quarter. OLD Dominion Capital Management Inc. now owns 56,266 shares of the financial services provider’s stock valued at $10,243,000 after acquiring an additional 1,410 shares in the last quarter. Forte Capital LLC ADV raised its stake in shares of CME Group by 7.7% in the 4th quarter. Forte Capital LLC ADV now owns 33,792 shares of the financial services provider’s stock worth $6,152,000 after buying an additional 2,430 shares in the last quarter. IFP Advisors Inc raised its stake in shares of CME Group by 16.9% in the 4th quarter. IFP Advisors Inc now owns 1,948 shares of the financial services provider’s stock worth $354,000 after buying an additional 281 shares in the last quarter. IBM Retirement Fund raised its stake in shares of CME Group by 14.1% in the 4th quarter. IBM Retirement Fund now owns 13,178 shares of the financial services provider’s stock worth $2,399,000 after buying an additional 1,627 shares in the last quarter. Finally, Prana Capital Management LP bought a new stake in shares of CME Group in the 3rd quarter worth $4,988,000. 83.88% of the stock is currently owned by hedge funds and other institutional investors.

In other news, insider Hilda Harris Piell sold 2,300 shares of the company’s stock in a transaction dated Monday, December 21st. The stock was sold at an average price of $182.00, for a total transaction of $418,600.00. Following the completion of the sale, the insider now owns 39,704 shares in the company, valued at approximately $7,226,128. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Martin J. Gepsman sold 800 shares of the business’s stock in a transaction dated Tuesday, December 1st. The stock was sold at an average price of $178.60, for a total value of $142,880.00. Following the transaction, the director now directly owns 29,817 shares of the company’s stock, valued at approximately $5,325,316.20. The disclosure for this sale can be found here. In the last quarter, insiders have sold 12,559 shares of company stock valued at $2,267,616. 1.20% of the stock is currently owned by corporate insiders.

Shares of CME traded up $4.88 during trading hours on Monday, hitting $186.62. 67,409 shares of the company were exchanged, compared to its average volume of 1,760,589. The company has a market cap of $66.99 billion, a PE ratio of 30.29 and a beta of 0.46. The firm’s 50 day moving average is $185.98 and its 200-day moving average is $172.43. CME Group Inc. has a 52 week low of $131.80 and a 52 week high of $225.36. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

The business also recently declared a None dividend, which was paid on Wednesday, January 13th. Stockholders of record on Monday, December 28th were paid a dividend of $2.50 per share. The ex-dividend date was Thursday, December 24th. CME Group’s dividend payout ratio (DPR) is presently 50.00%.

CME has been the topic of a number of research reports. Barclays boosted their price objective on CME Group from $200.00 to $215.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 12th. JPMorgan Chase & Co. upgraded CME Group from an “underweight” rating to a “neutral” rating and lifted their price target for the company from $138.00 to $203.00 in a report on Thursday, January 7th. Oppenheimer downgraded CME Group from an “outperform” rating to a “market perform” rating in a report on Friday, January 15th. They noted that the move was a valuation call. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and set a $196.00 price target on the stock. in a report on Friday, January 8th. They noted that the move was a valuation call. Finally, Zacks Investment Research downgraded CME Group from a “buy” rating to a “hold” rating and set a $205.00 price target on the stock. in a report on Thursday, January 7th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $188.06.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

Featured Story: Quick Ratio

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.